Welcome to the International Society for Vaccines
User account menu
Show — User account menu
Hide — User account menu
Log in
Sign Here
Login
Remember me
Remember password
Greetings: Create an account
Main navigation
Show — Main navigation
Hide — Main navigation
Home
ABOUT ISV
IetpShops STORE , Nike ACG GPX DOLPHIN HOODIE "GREY HEATHER" , DH1574 - 050 , nike mens air prestige iii 3 low power
IetpShops SB - adidas ultra boost vegan shoes 2017 ADIDAS by Stella McCartney - yeezy display font size chart conversion
Nike Air Jordan 1 Blancas y Negras por 64 , 95 € , air jordan 1 mid coconut milk particle grey ps UK 10, Oferta, Envío Gratis
Prices & Collaborations , dc0774 Dates , Sneaker Calendar, Air Jordan 2 Retro Low "O.G.", Jordan , nike air jordan 12 retro indigo stone blue mens
nike air force with laces on back shoes sale free Low LeBronival DM1058 , SBD - nike shox gravity resell store in india price - 500 Release Date
air jordan 12 retro flu game
nike air max 1 travis scott cactus jack baroque brown do9392 200
air jordan 4 black canvas
417944 nike air max plus
Air Jordan 1 Mid Invert Split Black White DR0501 101 Release Date 4
ISV Constitution
ISV History
ISV Fellows
Officers & Board
Congress
Papers
Paper of the Year
Paper of the Month
Membership
Become An ISV Member
Existing Member Login
Main navigation
Show — Main navigation
Hide — Main navigation
Home
ABOUT ISV
ISV Constitution
ISV History
ISV Fellows
Officers & Board
Congress
Papers
Paper of the Year
Paper of the Month
Membership
Become An ISV Member
Existing Member Login
Skip to main content
ISV - The International Society for Vaccines
Breadcrumb
ISV Home
The Paper of month
The Paper of month
Date (field_date3)
And
December, 2016
A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease
December, 2016
In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine
January, 2016
Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose